Comparison Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Incidence of Lung Cancer: A Retrospective Study

Introduction: Angiotensin-converting enzyme inhibitor (ACEI) and angiotensin II receptor blockers (ARBs) are taken as the first treatment option for hypertensive patients. The various global trials have suggested that ACEIs and ARBs may increase risk of lung cancer; however, the results are contradi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cureus
Main Authors: Kumar, Pardeep, Kumar, Vinod, Murlidhar, Manish, Fatima, Aliya, Jahangir, Maha, Khalid, Dua, Memon, Muhammad Khizar, Memon, Sidra, Kumar, Besham
Formato: Artigo
Idioma:Inglês
Publicado: Cureus 2021
Assuntos:
Cardiology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8168993/
https://ncbi.nlm.nih.gov/pubmed/34094750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.14788
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares